Petros Pharm Inc (PTPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,319 | -5,045 | -2,825 | -2,163 | -8,163 |
| Depreciation Amortization | N/A | N/A | N/A | N/A | 3,415 |
| Accounts receivable | N/A | N/A | N/A | N/A | -144 |
| Accounts payable and accrued liabilities | 352 | -68 | -212 | -48 | -93 |
| Other Working Capital | -267 | -429 | -32 | 17 | 625 |
| Other Operating Activity | 11,631 | 1,974 | 271 | 1,059 | -3,266 |
| Operating Cash Flow | $-2,603 | $-3,569 | $-2,797 | $-1,135 | $-7,627 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -19 | N/A | N/A | N/A |
| Other Investing Activity | -25 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-25 | $-19 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -1,464 |
| Other Financing Activity | -6,999 | -5,855 | -3,080 | -1,121 | 13,001 |
| Financing Cash Flow | $-6,999 | $-5,855 | $-3,080 | $-1,121 | $11,537 |
| Beginning Cash Position | 13,337 | 13,337 | 13,337 | 13,337 | 9,426 |
| End Cash Position | 3,710 | 3,895 | 7,460 | 11,081 | 13,337 |
| Net Cash Flow | $-9,627 | $-9,442 | $-5,877 | $-2,256 | $3,911 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,603 | -3,569 | -2,797 | -1,135 | -7,627 |
| Capital Expenditure | N/A | -19 | N/A | N/A | N/A |
| Free Cash Flow | -2,603 | -3,588 | -2,797 | -1,135 | -7,627 |